Biotech Grünenthal receives FDA Orphan Drug and Rare Pediatric Disease Designations for Tegacorat for the Treatment of Duchenne Muscular Dystrophy August 1, 2026
Biotech WuXi Biologics Achieves MSCI ESG AAA Rating and MSCI Selection Indexes Inclusion for Fourth Consecutive Year July 31, 2026
Biotech RYBODYN AWARDED $1.3M DOW GRANT TO ADVANCE NOVEL ANTIBODY THERAPIES FOR LUNG CANCER July 30, 2026
Biotech Blue Earth Therapeutics announces first participant dosed in Phase 1 clinical trial investigating Actinium (²²⁵Ac) rhPSMA-10.1 Injection in metastatic castration-resistant prostate cancer July 29, 2026
Biotech InxMed Announces Publication in The Lancet Respiratory Medicine Featuring Promising Anticancer Activity of Ifebemtinib in combination with Garsorasib in First-Line non-small cell lung cancer (NSCLC) Harboring KRAS G12C Mutation July 28, 2026
Biotech Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2026 Financial Results July 26, 2026
Search
Biotech
August 4, 2026
August 3, 2026
August 2, 2026
August 1, 2026
July 31, 2026
July 30, 2026
July 29, 2026
July 28, 2026
July 27, 2026
July 26, 2026
